+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Merck & Co., Inc. - logo

Merck & Co., Inc. is a global healthcare company with operations in more than 140 countries. It offers therapeutic and preventive agents to treat cardiovascular, type 2 diabetes, asthma, nasal allergy symptoms, allergic rhinitis, chronic hepatitis C virus and other diseases. The company has collaboration agreements with Adaptimmune Therapeutics plc and Agenus; and a research agreement with Proteros Biostructures. Founded in 1891, it is headquartered in Kenilworth, New Jersey.

From
Sexually Transmitted Diseases (STD) Treatment Market 2024-2028 - Product Thumbnail Image

Sexually Transmitted Diseases (STD) Treatment Market 2024-2028

  • Report
  • October 2024
  • 145 Pages
  • Global
From
Angiotensin Receptor Blockers (ARBs) Market Report 2025 - Product Thumbnail Image

Angiotensin Receptor Blockers (ARBs) Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
From
Human Papilloma Virus (HPV) Market - Forecasts from 2019 to 2024 - Product Thumbnail Image

Human Papilloma Virus (HPV) Market - Forecasts from 2019 to 2024

  • Report
  • November 2019
  • 115 Pages
  • Global
From
Barth Syndrome Treatment - Global Strategic Business Report - Product Thumbnail Image

Barth Syndrome Treatment - Global Strategic Business Report

  • Report
  • July 2025
  • 486 Pages
  • Global
From
Neurology Clinical Trials Market Report 2023-2033 - Product Thumbnail Image

Neurology Clinical Trials Market Report 2023-2033

  • Report
  • January 2023
  • 262 Pages
  • Global
From
From
Regenerative Medicine Market 2025-2029 - Product Thumbnail Image

Regenerative Medicine Market 2025-2029

  • Report
  • March 2025
  • 225 Pages
  • Global
From
From
Open-angle Glaucoma Therapeutics Market 2024-2028 - Product Thumbnail Image

Open-angle Glaucoma Therapeutics Market 2024-2028

  • Report
  • September 2024
  • 163 Pages
  • Global
From
PD-1 and PD-L1 Inhibitors - Global Strategic Business Report - Product Thumbnail Image

PD-1 and PD-L1 Inhibitors - Global Strategic Business Report

  • Report
  • July 2025
  • 376 Pages
  • Global
From
Anti-Inflammatory Drugs - Global Strategic Business Report - Product Thumbnail Image

Anti-Inflammatory Drugs - Global Strategic Business Report

  • Report
  • July 2025
  • 488 Pages
  • Global
From
Loading Indicator